Connect with us
European Gaming Congress 2024

Artificial Intelligence

Global Medical Radiation Detection Market Report 2023: Increasing Use of Diagnostic Imaging Drives Growth

Published

on

<!– Name:DistributionId Value:8842290 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:2790 –> <!– Name:CustomerId Value:1026737 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:d1ca1fc0-89e7-4134-9e37-940ea3394650 –>

Dublin, May 18, 2023 (GLOBE NEWSWIRE) — The “Medical Radiation Detection Market Size, Share & Trends Analysis Report By Type (Gas-filled Detector, Scintillators), By Product (Personal Dosimeters, Area Process Dosimeters), By End-use, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global medical radiation detection market size is expected to reach USD 1, 683.35 million by 2030. The market is expected to expand at a CAGR of 7.53% from 2023 to 2030.

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • UAB Polimaster Europe
  • PTW Freiburg GmbH
  • ATOMTEX
  • Sanlar imex services private limited
  • LANDAUER
  • Mirion Technologies, Inc
  • MP BIOMEDICALS.
  • SIERRA RADIATION DOSIMETRY SERVICE, INC.
  • IBA Dosimetry GmbH

The primary factor driving the industry is due to greater demand for radiation detection and medical diagnostics.

As per the estimates CDC in 2020 cancer was the second leading cause of death in the U.S. The increase in the prevalence of this disease is fuelling the demand for the treatment which in turn, is influencing the demand for detection devices. Additionally advancements in technology such as the use of artificial intelligence and nanotechnology aid in detecting the very low level of radiation with high accuracy further influencing the growth of the market.

The COVID-19 pandemic has had a significant impact on the medical radiation detection, monitoring and safety market. Radiation therapy is a critical component of cancer treatment, and the pandemic has disrupted cancer diagnosis and treatment globally. Many cancer patients have been forced to postpone or cancel their radiation therapy treatments due to the pandemic’s limitations on healthcare systems and resources.

Advertisement
Stake.com

The pandemic has also resulted in a decline in the number of cancer diagnoses, which has led to a decrease in the demand for radiation therapy.

Furthermore, the COVID-19 outbreak had disrupted global supply chains and caused delays in the delivery of radiation therapy equipment and supplies.

However. The market has also accelerated the adoption of advanced technologies in radiation therapy, such as image-guided radiation therapy and proton therapy, which can improve treatment outcomes and reduce the risk of side effects. These advancements are expected to drive the growth of the medical radiation therapy market over the forecast period.

Medical Radiation Detection Market Report Highlights

  • In 2022, North America dominated the market in terms of the revenue share by 34.20%. This is attributed to growing concern about the potential risks associated with exposure to ionizing radiation in medical procedures
  • In 2022, based on product, personal dosimeters accounted for the highest revenue share in 2022 owning to its properties such as being lightweight, and easy to access
  • On the basis of type, gas-filled detectors accounted for the highest revenue share in 2022 owning popularity due to several advantages they offer over other types of radiation detectors
  • On the basis of end-use. The hospitals segment accounted for the highest revenue share in 2022. This is attributed to the increasing geriatric population and an increase in chronic diseases, there is a growing demand for medical imaging procedures, such as X-rays, CT scans, and PET scans

Key Attributes:

Report Attribute Details
No. of Pages 150
Forecast Period 2022 – 2030
Estimated Market Value (USD) in 2022 $944.52 Million
Forecasted Market Value (USD) by 2030 $1683.35 Million
Compound Annual Growth Rate 7.5%
Regions Covered Global

Key Topics Covered:

Advertisement
Stake.com

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.1.1 Radiation Detection, Monitoring And Safety Market Market
3.1.2 Related/Ancillary Market Outlook
3.1.2.1 Radiation Oncology Market
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.2. Increasing Use of Diagnostic Imaging
3.2.3 Growing Awareness of Radiation Risks
3.2.4 Market Restraint Analysis
3.2.2.1 Lower Adoption in Emerging Economies
3.2.2.2 High Cost and Lack of Skilled Work Professional
3.2.3 COVID 19 IMPACT
3.3 Medical Radiation Detection Market Analysis Tools
3.3.1 Industry Analysis – Porter’s
3.3.2 Pestel Analysis

Chapter 4 Medical Radiation Detection Market, By Type 2018 – 2030 (USD Million)
4.1 Type Market Share Analysis
4.2 Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.3.1 Gas-Filled Detectors
4.3.1.1 Gas-Filled Detectors Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.3.2 Scintillators
4.3.2.1 Scintillators Market Estimates And Forecast, 2018 – 2030 (USD Million)
4.3.3 Solid-State
4.3.3.1 Solid-State Market Estimates And Forecast, 2018-2030 (USD Million)

Chapter 5 Medical Radiation Detection Market Analysis, By Product 2018 – 2030 (USD Million)
5.1 Application Market Share Analysis
5.2 Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.3.1 Personal Dosimeters
5.3.1.1 Personal Dosimeters Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3.2 Area Process Dosimeters
5.3.2.1 Area Process Dosimeters Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3.3 Surface Contamination Monitors
5.3.3.1 Surface Contamination Monitors Market Estimates And Forecast, 2018 – 2030 (USD Million)
5.3.4 Others
5.3.4.1 Others Market Estimates And Forecast, 2018-2030 (USD Million)

Advertisement
Stake.com

Chapter 6 Medical Radiation Detection Market Segment Analysis, By End-Use 2018 – 2030 (USD Million)
6.1 End-Use Market Share Analysis
6.2 Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.3.1 Hospitals
6.3.1.1 Hospitals Market Estimates And Forecast, 2018 – 2030 (USD Million)
6.3.2 Ambulatory Surgical Centers
6.3.2.1 Ambulatory Surgical Centers Estimates And Forecast, 2018 – 2030 (USD Million)
6.3.3 Diagnostic Imaging Centers
6.3.3.1 Diagnostic Imaging Centers Estimates And Forecast 2018-2030 (USD Million)
6.3.4 Homecare
6.3.4.1 Homecare Market Estimates And Forecast, 2018-2030 (USD Million)

Chapter 7 Medical Radiation Detection Market Regional Market Analysis, 2018-2030 (USD Million)

Chapter 8 Medical Radiation Detection Market: Competitive Market Analysis

For more information about this report visit https://www.researchandmarkets.com/r/3ukdel

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Advertisement
Stake.com

Attachment


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

ZA Tech Rebrands as Peak3, Raises US$35M Series A led by EQT

Published

on

za-tech-rebrands-as-peak3,-raises-us$35m-series-a-led-by-eqt

SINGAPORE, June 19, 2024 /PRNewswire/ — ZA Tech, the next-generation insurance core system SaaS provider, has rebranded as Peak3. With the successful completion of its US$35 million Series A fundraising from EQT (lead investor) and Alpha JWC Ventures, Peak3 now accelerates its expansion in the EMEA region and investments in complementary data and AI solutions.

In a market dominated by fragmented legacy technology, Peak3 has pioneered a cloud-native, modular insurance core and distribution system that combines comprehensive capabilities for life, health, and property and casualty (P&C) insurance. Since its founding in 2018, Peak3 has become a trusted technology partner to global insurers such as AIA, Generali, Prudential, and Zurich for their digital and traditional business. It has also partnered with leading digital platforms such as Carro, Grab, Klook, and PayPay to build and scale their embedded insurance businesses.
Besides the successful fundraising, Peak3 has recently achieved key milestones underpinning the rebranding. These transformative achievements include launching its first multi-country, multi-tenant core modernisation in Europe, rolling out an integrated customer data and big data platform for scaling analytics and AI capabilities, and establishing its first technology centre in Europe. The rebranding coincides with another major milestone: Issuing over a billion insurance policies on Peak3’s systems – including the first policies issued to North American customers and the first ones to be issued in Africa.
“We have evolved from an embedded insurance pioneer in Asia to a global end-to-end technology partner for the insurance industry,” said Bill Song, Peak3 Group CEO and Co-Founder. “Our new name represents three pinnacles: scaling the heights of innovation, surpassing performance limits, and delivering superior reliability – as we help insurers reach the highest summits of their cloud, data, and AI transformation.”
Bill Song also emphasised the growth opportunity: “There is an incredible tech investment backlog in the US$7-trillion global insurance industry. Continued digitalisation and the proliferation of AI will require structural investments by insurers over the next decade to modernise their core systems. We are uniquely positioned to capture this opportunity by providing the tech core foundations and innovation use cases.” 
To accelerate its growth journey, Peak3 completed its Series A fundraising and welcomed two new investors on its cap table: EQT, a major global technology investor with a deep heritage in Europe, and Alpha JWC Ventures, a leading venture firm in Southeast Asia. With the funding, Peak3 will advance its analytics and AI capabilities toward an intelligent core insurance solution, grow its EMEA operations and establish new system integrator partnerships. Peak3 targets double-digit ARR growth this year and is on the path to reach cashflow breakeven over the coming quarters.
“Peak3 has also proven its capability to deliver greenfield digital insurance initiatives and complex multi-country core modernisation projects in APAC and EMEA. As the lead investor, EQT is committed to empowering Peak3 in its go-to-market acceleration by leveraging our global network,” stated Clara Ho, Partner at EQT.
J.P. Morgan acted as exclusive financial advisor to Peak3 for this Series A fundraising.
For media inquiries and interview requests, please contact Carling Sia, Global Head of Branding and Marketing, at [email protected].
For more information on Peak3, please visit www.peak3.com. For more information on EQT, please visit www.eqtgroup.com.For more information on Alpha JWC Ventures, please visit www.alphajwc.com.
Photo – https://mma.prnewswire.com/media/2439599/Peak3_PR_Announcement_Photo__002.jpg

View original content:https://www.prnewswire.co.uk/news-releases/za-tech-rebrands-as-peak3-raises-us35m-series-a-led-by-eqt-302175431.html

Continue Reading

Artificial Intelligence

Lucinity Recognized as One of the Top 100 AI Fintech Companies Globally

Published

on

lucinity-recognized-as-one-of-the-top-100-ai-fintech-companies-globally

REYKJAVIK, Iceland, June 18, 2024 /PRNewswire/ — Lucinity has been featured in the AIFinTech100 list for 2024, marking its recognition as one of the top AI companies in the financial services industry. The AIFinTech100 list, curated by industry experts, highlights the most innovative fintech companies globally. Lucinity was selected from over 2,000 fintech firms for its problem-solving, market potential, innovation, and customer engagement. Earlier this year, Lucinity was also highlighted as a RegTech100 company.

 
 
This recognition comes amid rapid AI adoption in fintech. According to Fintech Global, research predicts the AI market in fintech will grow from $42.83 billion to $44.08 billion by 2024, reaching $50.87 billion by 2029. Banks alone are expected to spend $4.9 billion on AI platforms by 2024, with a 21.8% annual growth rate since 2019.
Lucinity’s inclusion in the AIFinTech100 list reflects its success in developing AI solutions that enhance efficiencies and cost savings for financial crime operations teams. Notably, Luci, the world’s first Generative AI copilot for financial crime investigations, launched in 2023, leverages Microsoft OpenAI technologies to augment human analysts’ capabilities, reducing investigation times from 3 hours to just 30 minutes. 
Lucinity also recently launched Luci as a copilot plugin at Money20/20. Financial institutions are now able to integrate Luci with any web-based enterprise application including CRM systems, Case Manager systems, and Excel, delivering immediate ROI with zero upfront integration. 
Security remains a significant challenge in AI adoption. Lucinity addresses this by partnering with Microsoft Azure develop a secure infrastructure. With a strong emphasis on compliance, Luci offers comprehensive auditability through its detailed Audit Log functionality.
Guðmundur Kristjánsson (GK), CEO of Lucinity, comments, “Being named in the AIFinTech100 showcases our impact amongst banks and fintech through advanced AI. It underscores our platform’s ability to empower compliance teams, deliver ROI, and reduce operational costs.”
Richard Sachar, Director of FinTech Global, added, “AI is revolutionizing financial services, increasing efficiencies and offering personalized products. This year’s AIFinTech100 list includes top innovators transforming the industry with AI applications.”
Lucinity’s inclusion in the AIFinTech100 list for 2024 follows several achievements, including winning the Microsoft Partner of the Year Awards for Sustainability and Social Impact and Partner of the Year – Iceland. Lucinity was also included in Chartis Research’s FinCrime and Compliance 50 Ranking for 2024 and was recognized as the best tool for Workflow Automation.
Name: Celina PabloEmail: [email protected] +354 792 4321
Logo – https://mma.prnewswire.com/media/2208676/4770157/Lucinity_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/lucinity-recognized-as-one-of-the-top-100-ai-fintech-companies-globally-302176061.html

Continue Reading

Artificial Intelligence

CRISIL wins Model Validation Tools and Accelerators category award, other recognitions from Chartis

Published

on

crisil-wins-model-validation-tools-and-accelerators-category-award,-other-recognitions-from-chartis

Recognized among top 50 financial services firms for analytics and risk tech
MUMBAI, India, June 18, 2024 /PRNewswire/ — CRISIL, a global provider of advanced analytics and risk management solutions, has won the Solution Category award for Model Validation Tools and Accelerators as part of the latest Chartis STORM 2024 report.

Published by Chartis Research, the leading provider of research and analysis on the global market for risk technology, STORM 2024 is an annual report on quantitative technologies and the computational infrastructure supporting it.
Following an extensive evaluation process, which included a risk technology survey, product demo, customer reference checks, and third-party sources of information, CRISIL won the following recognitions:
Solution category award for Model Validation Tools and AcceleratorsRanked Top 25 (#24) in QuantTech50 2024 rankingsRanked Top 25 (#24) in BuySideRisk50 2024 rankingsRanked Top 50 (#38) in RetailFinanceAnalytics50 2024 rankingsThe recognitions reflect the unparalleled value CRISIL brings to its clients through deep domain expertise, specialized analytical and technical knowledge and our global perspective.
Says Jan Larsen, President and Head, CRISIL Global Research & Risk Solutions, “CRISIL is honored by the recognition across multiple STORM50 award categories this year, including being named first place for Model Validation Tools and Accelerators. This is a great testament to the contributions of our team in giving clients and their regulators confidence in the models they use for making critical decisions.”
The core tenets of CRISIL’s value proposition include expertise across asset classes and risk stripes, analytical excellence and regulatory experience, tailored solutions focused on client delight, continuous improvement and technological innovation. 
Says Ashish Vora, President, CRISIL Market Intelligence and Analytics, “This prestigious recognition underscores the global acceptance of our risk management solutions and highlights our unwavering commitment to excellence in the risk technology space. Our Credit+ technology solutions have been instrumental in offering AI-enabled advanced analytics and driving efficiency, and we are particularly proud of the exceptional client feedback we have received for these solutions. We are constantly exploring new ways to enhance customer value and are investing in cutting-edge technology and domain expertise to maintain our position at the forefront of the industry.”
Notable examples of CRISIL’s platforms that help demonstrate this value proposition include: 
Model Infinity: A leading platform for model inventory management and model risk management. This innovative platform empowers our client to centralize all model activities, eliminates manual processes and operational risk, and provides a full audit trail of approvals for modeling assumptions and updates. Scenario Expansion Manager (SEM): A platform for clients to expand, analyze and track all regulatory and internal scenarios used for stress testing. As a centralized repository of scenarios, SEM allows institutions to eliminate redundant internal work and even provide clients the ability to share internal scenarios with one another. Credit+ ICON: The platform enables credit decision-making through its extensive financial spreading and front-end based credit risk scorecard hosting capabilities. Powered by deep domain expertise, AI-driven analytics and extensive configurability, it serves 40+ global clients across 15 countries.Credit+ Early Warning Signals: The AI-powered solution provides banks with actionable insights to monitor their credit quality, lower loan-loss contingencies and track corrective action plan.About CRISIL Market Intelligence & Analytics
About Global Research & Risk Solutions
About CRISIL Limited
Connect with us: LINKEDIN | TWITTER | YOUTUBE | FACEBOOK 
CRISIL PRIVACY
Disclaimer
This press release is transmitted to you for the sole purpose of dissemination through your newspaper/ magazine/ agency. The press release may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution of its press releases for consideration or otherwise through any media including websites, portals, etc.
CRISIL has taken due care and caution in preparing this press release. Information has been obtained by CRISIL from sources which it considers reliable. However, CRISIL does not guarantee the accuracy, adequacy or completeness of information on which this press release is based and is not responsible for any errors or omissions or for the results obtained from the use of this press release. CRISIL, especially states that it has no financial liability whatsoever to the subscribers/ users/ transmitters/ distributors of this press release.
Logo – https://mma.prnewswire.com/media/2211784/4276223/CRISIL_logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/crisil-wins-model-validation-tools-and-accelerators-category-award-other-recognitions-from-chartis-302175882.html

Continue Reading

Trending